Castrate-resistant Prostate Cancer

• CLINICAL_TRIALS research · 2026-01-07
  Clinical Trial Update: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas [Phase 1]

  DR-0202 is being studied in a Phase 1 trial across multiple locally advanced or metastatic carcinomas; the study is currently recruiting.

• CLINICAL_TRIALS trial_result · 2023-10-06
  Clinical Trial Update: Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC) [Phase 1, Phase 2]

  Phase 1/2 safety and tolerability update for ISIS EIF4E Rx in combination with docetaxel and prednisone in castration-resistant prostate can…

• CLINICAL_TRIALS trial_result · 2018-10-01
  Clinical Trial Update: A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) [Phase 1]

  Phase 1 dose-finding study of birabresib (MK-8628), a BET inhibitor, completed with results posted in 2018 for selected advanced solid tumor…

• CLINICAL_TRIALS trial_result · 2015-03-05
  Clinical Trial Update: Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer [Phase 3]

  A Phase 3 trial evaluated denosumab for prolonging bone metastasis-free survival in men with castrate-resistant prostate cancer. The results…